Neuphoria Therapeutics Inc. (NEUP) stock
NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
$2.55−0.03 (-1.16%)
Close on Nov 13, 2026Market cap $76.66KP/E –Yield –
Neuphoria Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Neuphoria Therapeutics's total assets was $28.71M at Jun 30, 2026. For fiscal 2026 it was $28.71M, up 0.4% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $28.71M | +0.4% |
| FY2025 | Jun 30, 2025 | $28.59M | +3.4% |
| FY2024 | Jun 30, 2024 | $27.65M | -3.2% |
| FY2023 | Jun 30, 2023 | $28.56M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $28.71M | +0.4% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $34.81M | +13.3% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $36.60M | +101.4% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $27.34M | +19.3% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $28.59M | +3.4% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $30.71M | +7.5% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $18.17M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $22.92M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $27.65M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $28.56M | – |
See a number that looks wrong?